InvestorsHub Logo

tradero

07/15/15 6:53 AM

#226287 RE: biopharm #226276

Correct Bio, this is the transcription....

(Joe Shan)<<To protect the integrity of this double-blind trial, an independent data monitoring committee has been established to evaluate safety data on an ongoing basis and make recommendations to Peregrine as to when the trial should be unblinded. As the interim analyses are triggered after pre-specified numbers of trial events are reached, in this case, deaths, we cannot, at this point, guide to when these might be reached, but we will be sure to provide updates as soon as we can.